Lenalidomide‐based response‐adapted therapy for older adults without high risk myeloma-Reference-Cited by-同舟云学术

Lenalidomide‐based response‐adapted therapy for older adults without high risk myeloma

Published:2018-12-12 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Baz Rachid¹^ORCID,Naqvi Syeda Mahrukh Hussnain²,Lee Jae‐Hoon³,Brayer Jason¹,Hillgruber Nancy¹,Fridley Brooke L.²,Shain Kenneth H.¹,Sullivan Daniel M.⁴,Alsina Melissa⁴

Affiliation:

1. Department of Malignant Haematology H. Lee Moffitt Cancer Center and Research Institute Tampa FL USA

2. Department of Biostatistics H. Lee Moffitt Cancer Center and Research Institute Tampa FL USA

3. Hematology Gil Medical Center Gachon University College of Medicine Incheon Korea

4. Department of Blood and Marrow Transplantation and Cellular Immunotherapy H. Lee Moffitt Cancer Center and Research Institute Tampa FL USA

Funder

Celgene

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15700

Reference25 articles.

1. Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis

2. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

3. Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

4. Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010

5. International uniform response criteria for multiple myeloma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features;Current Problems in Cancer;2021-08

2. Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma;Molecular Oncology;2021-07-24